Good candidate vaccines should be able to induce a complex immune response mainly characterized by proinflammatory pattern, cytotoxic CD8+ T-cells and Th1 and Th17 CD4+ T-cells, but also by some anti-inflammatory profile (IL-10), as demonstrated by the proved brucellosis vaccines. This evidence concerns the gene IL10 and brucellosis.